Iranian Society of Gynecology Oncology

Document Type : Original Research Article

Authors

Department of Obstetrics & Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background & Objective: Cervical Cancer (CC) is a common cancer which is associated with HPV-infection. The aim of this study is to investigate the risk factors which affects HPV-clearance.
Materials & Methods: This study was carried out on women with high risk HPV infection. All the patients underwent pap smears and cervical biopsy. Demographic data, marital status, vaccination history and consumption of tobacco, alcohol, opium and oral contraceptive pills were asked through a questionnaire. 
Results: 
The results showed that in one year follow-up, 142 (67.1%) patients showed HPV clearance. The HPV clearance decreased by increasing age (P=0.028) or higher CIN grades (P=0.017). In case of parity, there was no significant difference in univariate analysis (P=0.147), but it was significant in multiple logistic regression analysis (95% CI: 0.413-0.941, OR=0624, P= 0.024).
Conclusion: It seems that age and cervical histology at the start of HPV infection are the most important factors for HPV clearance.

Highlights

 It seems that age and cervical histology at the start of HPV infection are the most important factors for HPV clearance.

Keywords

Main Subjects

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. [DOI:10.3322/caac.21492] [PMID]
2. Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014;41(11):660. [DOI:10.1097/OLQ.0000000000000193] [PMID] [PMCID]
3. Schiffman M, Wentzensen N. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(4):553-60. [DOI:10.1158/1055-9965.EPI-12-1406] [PMID] [PMCID]
4. Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev. 2013;2(1):1-14. [DOI:10.1186/2046-4053-2-35] [PMID] [PMCID]
5. de Sanjose S, Brotons M, Pavon MA. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol. 2018;47:2-13. [DOI:10.1016/j.bpobgyn.2017.08.015] [PMID]
6. Panjaliya R, Dogra V, Gupta S. Study of the risk factors associated with cervical cancer. Biomed Pharmacol J. 2015;3(1):179-82.
7. Kim J, Song S, Jin C, Lee J, Lee N, Lee K. Factors affecting the clearance of high-risk human papillomavirus infection and the progression of cervical intraepithelial neoplasia. J Int Med Res. 2012;40(2):486-96. [DOI:10.1177/147323001204000210] [PMID]
8. Yoshikawa H, Nagata C, Noda K, Nozawa S, Yajima A, Sekiya S, et al. Human papillomavirus infection and other risk factors for cervical intraepithelial neoplasia in Japan. Br J Cancer. 1999;80(3):621-4. [DOI:10.1038/sj.bjc.6690401] [PMID] [PMCID]
9. Fukuchi E, Sawaya GF, Chirenje M, Magure T, Tuveson J, Ma Y, et al. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Trans Dis. 2009:305-11. [DOI:10.1097/OLQ.0b013e318194eb76] [PMID]
10. Hernández-Suárez G, Ortiz N, González M, Muñoz N. Short-term risk of cervical intraepithelial neoplasia grades 2 and 3 for women with normal cytology and human papillomavirus infection. salud pública de méxico. 2010;52(6):486-92. [DOI:10.1590/S0036-36342010000600002] [PMID]
11. Guo Y-l, You K, Qiao J, Zhao Y-m, Liu C-r, Geng L. Natural history of infections with high-risk HPV in Chinese women with abnormal cervical cytology findings at baseline. Int J Gynecol Obstet. 2010;110(2):137-40. [DOI:10.1016/j.ijgo.2010.03.021] [PMID]
12. Cancer ICoESoC. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer. 2006;119(5):1108-24. [DOI:10.1002/ijc.21953] [PMID]
13. Castle PE, Walker JL, Schiffman M, Wheeler CM. Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA‐positive women with equivocal or mildly abnormal cytology. International journal of cancer. 2005;117(6):1007-12. [DOI:10.1002/ijc.21279] [PMID]
14. Soheili M, Keyvani H, Soheili M, Nasseri S. Human papilloma virus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers. Med J Islam Rep Iran. 2021;35:65. [DOI:10.47176/mjiri.35.65] [PMID] [PMCID]
15. Allameh T, Moghim S, Asadi-Zeidabadi M. A survey on the prevalence of high-risk subtypes of human papilloma virus among women with cervical neoplasia in Isfahan University of Medical Science. Arc gynecol obstet. 2011;284(6):1509-13. [DOI:10.1007/s00404-011-1863-4] [PMID]
16. Chen H-C, Schiffman M, Lin C-Y, Pan M-H, You S-L, Chuang L-C, et al. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst. 2011;103(18):1387-96. [DOI:10.1093/jnci/djr283] [PMID] [PMCID]
17. Söderlund‐Strand A, Kjellberg L, Dillner J. Human papillomavirus type‐specific persistence and recurrence after treatment for cervical dysplasia. J Med Virol. 2014;86(4):634-41. [DOI:10.1002/jmv.23806] [PMID]
18. Demarco M, Hyun N, Carter-Pokras O, Raine-Bennett TR, Cheung L, Chen X, et al. A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs. EClinicalMedicine. 2020;22:100293. [DOI:10.1016/j.eclinm.2020.100293] [PMID] [PMCID]
19. Murenzi G, Tuyisenge P, Kanyabwisha F, Munyaneza A, Muhoza B, Kubwimana G, et al. Type-specific persistence, clearance and incidence of high-risk HPV among screen-positive Rwandan women living with HIV. Infectious agents and cancer. 2021;16(1):1-9. [DOI:10.1186/s13027-021-00355-6] [PMID] [PMCID]
20. Carcopino X, Bolger N, Henry M, Mancini J, Boubli L, Olive D, et al. Evaluation of type‐specific HPV persistence and high‐risk HPV viral load quantitation in HPV positive women under 30 with normal cervical cytology. J Med Virol. 2011;83(4):637-43. [DOI:10.1002/jmv.22022] [PMID]
21. García-Piñeres AJ, Hildesheim A, Herrero R, Trivett M, Williams M, Atmetlla I, et al. Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women. Cancer Res. 2006;66(22):11070-6. [DOI:10.1158/0008-5472.CAN-06-2034] [PMID]
22. Sammarco ML, Del Riccio I, Tamburro M, Grasso GM, Ripabelli G. Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy. Eur J Obstet Gynecol Reproduct Biol. 2013;168(2):222-6. [DOI:10.1016/j.ejogrb.2013.01.012] [PMID]
23. Li M, Liu T, Luo G, Sun X, Hu G, Lu Y, et al. Incidence, persistence and clearance of cervical human papillomavirus among women in Guangdong, China 2007-2018: A retrospective cohort study. J Infect Public Heal. 2021;14(1):42-9. [DOI:10.1016/j.jiph.2020.11.011] [PMID]
24. Reis N, Beji N, Kilic D. Risk factors for cervical cancer: results from a hospital-based case-control study. UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi. 2011;21(3):153-9. [DOI:10.4999/uhod.09061]
25. Nieto K, Gissmann L, Schädlich L. Human papillomavirus-specific immune therapy: failure and hope. Ant ther. 2010;15(7):951-7. [DOI:10.3851/IMP1665] [PMID]
26. Song S-H, Lee J-K, Lee N-W, Saw H-S, Kang J-S, Lee K-W. Interferon-γ (IFN-γ): a possible prognostic marker for clearance of high-risk human papillomavirus (HPV). Gynecol Oncol. 2008;108(3):543-8. [DOI:10.1016/j.ygyno.2007.11.006] [PMID]
27. Hong JH, Kim MK, Lee IH, Kim TJ, Kwak SH, Song SH, et al. Association between serum cytokine profiles and clearance or persistence of high-risk human papillomavirus infection: a prospective study. Int J Gynecol Cancer. 2010;20(6):1011-6. [DOI:10.1111/IGC.0b013e3181e513e5] [PMID]
28. Michael CW, Esfahani FM. Pregnancy‐related changes: a retrospective review of 278 cervical smears. Diagnostic cytopathology. 1997;17(2):99-107. https://doi.org/10.1002/(SICI)1097-0339(199708)17:2<99::AID-DC4>3.0.CO;2-J [DOI:10.1002/(SICI)1097-0339(199708)17:23.0.CO;2-J]
29. Yang X, Jin G, Nakao Y, Rahimtula M, Pater MM, Pater A. Malignant transformation of HPV 16‐immortalized human endocervical cells by cigarette smoke condensate and characterization of multistage carcinogenesis. Int J Cancer. 1996;65(3):338-44. https://doi.org/10.1002/(SICI)1097-0215(19960126)65:3<338::AID-IJC11>3.0.CO;2-6 [DOI:10.1002/(SICI)1097-0215(19960126)65:33.0.CO;2-6]
30. Rachel Skinner S, Wheeler CM, Romanowski B, Castellsagué X, Lazcano‐Ponce E, Rowena Del Rosario‐Raymundo M, et al. Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study. Int J Cancer. 2016;138(10):2428-38. [DOI:10.1002/ijc.29971] [PMID] [PMCID]
31. Cancer ICoESoC. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies. Lancet. 2007;370(9599):1609-21. [DOI:10.1016/S0140-6736(07)61684-5] [PMID]
32. Zidi S, Sahli M, Mezlini A, Yacoubli-Loueslati B. Association of combined tobacco smoking, hormonal contraceptive use and status matrimonial with cervical cancer evolution in Tunisian women. Pathol Oncol Res. 2020;26(1):217-22. [DOI:10.1007/s12253-018-0442-4] [PMID]
33. Nagelhout G, Ebisch RM, Van Der Hel O, Meerkerk G-J, Magnée T, De Bruijn T, et al. Is smoking an independent risk factor for developing cervical intra-epithelial neoplasia and cervical cancer? A systematic review and meta-analysis. Exp Rev Ant Ther. 2021;21(7):781-94. [DOI:10.1080/14737140.2021.1888719] [PMID]
34. Seo SS, Oh HY, Kim MK, Lee DO, Chung YK, Kim J-Y, et al. Combined Effect of Secondhand Smoking and Alcohol Drinking on Risk of Persistent Human Papillomavirus Infection. BioMed Res Int. 2019;2019. [DOI:10.1155/2019/5829676] [PMID] [PMCID]
35. Oh H, Kim M, Seo S, Lee D, Chung Y, Lim M, et al. Alcohol consumption and persistent infection of high-risk human papillomavirus. Epidemiol Infect. 2015;143(7):1442-50. [DOI:10.1017/S0950268814002258] [PMID] [PMCID]
36. Xu H, Egger S, Velentzis LS, O'Connell DL, Banks E, Darlington-Brown J, et al. Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30-44 years: A case-control study in New South Wales, Australia. Cancer epidemiol. 2018;55:162-9. [DOI:10.1016/j.canep.2018.05.013] [PMID]
37. Oh HY, Seo S-S, Kim MK, Lee DO, Chung YK, Lim MC, et al. Synergistic effect of viral load and alcohol consumption on the risk of persistent high-risk human papillomavirus infection. PLoS One. 2014;9(8):e104374. [DOI:10.1371/journal.pone.0104374] [PMID] [PMCID]
38. Chelimo C, Wouldes TA, Cameron LD, Elwood JM. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J Infection. 2013;66(3):207-17. [DOI:10.1016/j.jinf.2012.10.024] [PMID]
39. Kilic D, Guler T, Atigan A, Avsaroglu E, Karakaya YA, Kaleli I, et al. Predictors of Human papillomavirus (HPV) persistence after treatment of high grade cervical lesions; does cervical cytology have any prognostic value in primary HPV screening? Annals of Diagnostic Pathology. 2020;49:151626. [DOI:10.1016/j.anndiagpath.2020.151626] [PMID]